publication date: Feb. 17, 2012
ODAC Votes to Nix Amgen’s Drug Xgeva for Proposed Prostate Cancer Indication Appropriations 2013: Obama Proposes Flat Funding for NIH Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials Download PDF 
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.